| UniProt ID | EI2BD_HUMAN | |
|---|---|---|
| UniProt AC | Q9UI10 | |
| Protein Name | Translation initiation factor eIF-2B subunit delta | |
| Gene Name | EIF2B4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 523 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP.. | |
| Protein Sequence | MAAVAVAVREDSGSGMKAELPPGPGAVGREMTKEEKLQLRKEKKQQKKKRKEEKGAEPETGSAVSAAQCQVGPTRELPESGIQLGTPREKVPAGRSKAELRAERRAKQEAERALKQARKGEQGGPPPKASPSTAGETPSGVKRLPEYPQVDDLLLRRLVKKPERQQVPTRKDYGSKVSLFSHLPQYSRQNSLTQFMSIPSSVIHPAMVRLGLQYSQGLVSGSNARCIALLRALQQVIQDYTTPPNEELSRDLVNKLKPYMSFLTQCRPLSASMHNAIKFLNKEITSVGSSKREEEAKSELRAAIDRYVQEKIVLAAQAISRFAYQKISNGDVILVYGCSSLVSRILQEAWTEGRRFRVVVVDSRPWLEGRHTLRSLVHAGVPASYLLIPAASYVLPEVSKVLLGAHALLANGSVMSRVGTAQLALVARAHNVPVLVCCETYKFCERVQTDAFVSNELDDPDDLQCKRGEHVALANWQNHASLRLLNLVYDVTPPELVDLVITELGMIPCSSVPVVLRVKSSDQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAVAVAVR ------CCEEEEEEE | 15.62 | 22814378 | |
| 10 (in isoform 2) | Phosphorylation | - | 50.35 | 29116813 | |
| 11 (in isoform 2) | Phosphorylation | - | 47.97 | 29116813 | |
| 12 | Phosphorylation | AVAVREDSGSGMKAE EEEEECCCCCCCCCC | 30.06 | 25159151 | |
| 14 | Phosphorylation | AVREDSGSGMKAELP EEECCCCCCCCCCCC | 39.40 | 23186163 | |
| 19 (in isoform 2) | Phosphorylation | - | 57.18 | 22777824 | |
| 21 (in isoform 2) | Phosphorylation | - | 24.25 | 26657352 | |
| 23 (in isoform 2) | Phosphorylation | - | 31.19 | 26434776 | |
| 36 | Malonylation | REMTKEEKLQLRKEK CCCCHHHHHHHHHHH | 42.50 | 26320211 | |
| 65 (in isoform 3) | Phosphorylation | - | 20.01 | - | |
| 73 (in isoform 3) | Phosphorylation | - | 29.44 | - | |
| 74 | Phosphorylation | AQCQVGPTRELPESG HHCCCCCCCCCCCCC | 30.74 | - | |
| 79 (in isoform 3) | Phosphorylation | - | 74.38 | - | |
| 80 | Phosphorylation | PTRELPESGIQLGTP CCCCCCCCCCCCCCC | 38.98 | 23927012 | |
| 85 (in isoform 3) | Phosphorylation | - | 19.80 | 25159151 | |
| 86 | Phosphorylation | ESGIQLGTPREKVPA CCCCCCCCCHHHCCC | 27.97 | 23401153 | |
| 86 (in isoform 2) | Phosphorylation | - | 27.97 | - | |
| 94 (in isoform 2) | Phosphorylation | - | 28.46 | - | |
| 100 (in isoform 2) | Phosphorylation | - | 8.21 | - | |
| 106 (in isoform 2) | Phosphorylation | - | 24.89 | 25159151 | |
| 129 (in isoform 3) | Phosphorylation | - | 32.23 | - | |
| 130 | Phosphorylation | GGPPPKASPSTAGET CCCCCCCCCCCCCCC | 26.05 | 29255136 | |
| 131 (in isoform 3) | Phosphorylation | - | 40.33 | - | |
| 132 | Phosphorylation | PPPKASPSTAGETPS CCCCCCCCCCCCCCC | 28.52 | 30266825 | |
| 133 | Phosphorylation | PPKASPSTAGETPSG CCCCCCCCCCCCCCC | 41.91 | 30266825 | |
| 136 (in isoform 3) | Phosphorylation | - | 55.89 | - | |
| 137 | Phosphorylation | SPSTAGETPSGVKRL CCCCCCCCCCCCCCC | 23.10 | 29255136 | |
| 139 | Phosphorylation | STAGETPSGVKRLPE CCCCCCCCCCCCCCC | 64.73 | 29255136 | |
| 142 | Ubiquitination | GETPSGVKRLPEYPQ CCCCCCCCCCCCCCC | 52.31 | - | |
| 142 | Acetylation | GETPSGVKRLPEYPQ CCCCCCCCCCCCCCC | 52.31 | 25953088 | |
| 147 | Phosphorylation | GVKRLPEYPQVDDLL CCCCCCCCCCHHHHH | 9.31 | - | |
| 147 | Nitration | GVKRLPEYPQVDDLL CCCCCCCCCCHHHHH | 9.31 | - | |
| 150 (in isoform 2) | Phosphorylation | - | 5.52 | 24719451 | |
| 152 (in isoform 2) | Phosphorylation | - | 40.12 | - | |
| 153 (in isoform 2) | Phosphorylation | - | 4.14 | 27251275 | |
| 157 (in isoform 2) | Phosphorylation | - | 43.75 | 24719451 | |
| 169 | Phosphorylation | PERQQVPTRKDYGSK HHHCCCCCCCCCCCC | 52.04 | 30576142 | |
| 175 | Ubiquitination | PTRKDYGSKVSLFSH CCCCCCCCCHHHHHC | 24.53 | 21890473 | |
| 176 (in isoform 1) | Ubiquitination | - | 31.32 | 21890473 | |
| 176 | Ubiquitination | TRKDYGSKVSLFSHL CCCCCCCCHHHHHCC | 31.32 | 21890473 | |
| 178 | Phosphorylation | KDYGSKVSLFSHLPQ CCCCCCHHHHHCCCC | 27.68 | 27080861 | |
| 181 | Phosphorylation | GSKVSLFSHLPQYSR CCCHHHHHCCCCCCC | 29.43 | 27080861 | |
| 186 | Phosphorylation | LFSHLPQYSRQNSLT HHHCCCCCCCCCCCH | 12.13 | 20873877 | |
| 187 | Phosphorylation | FSHLPQYSRQNSLTQ HHCCCCCCCCCCCHH | 23.34 | 20873877 | |
| 191 | Phosphorylation | PQYSRQNSLTQFMSI CCCCCCCCCHHHHCC | 25.18 | 28355574 | |
| 193 | Phosphorylation | YSRQNSLTQFMSIPS CCCCCCCHHHHCCCH | 21.41 | 28450419 | |
| 196 (in isoform 2) | Ubiquitination | - | 2.26 | 21890473 | |
| 197 (in isoform 2) | Ubiquitination | - | 32.41 | 21890473 | |
| 197 | Phosphorylation | NSLTQFMSIPSSVIH CCCHHHHCCCHHHHC | 32.41 | 27251275 | |
| 206 (in isoform 2) | Phosphorylation | - | 8.57 | 27251275 | |
| 207 (in isoform 2) | Phosphorylation | - | 1.81 | 27251275 | |
| 211 (in isoform 2) | Phosphorylation | - | 10.52 | 24719451 | |
| 213 (in isoform 2) | Phosphorylation | - | 33.75 | 27251275 | |
| 214 | Phosphorylation | MVRLGLQYSQGLVSG HHHHCCEECCCCCCC | 14.17 | - | |
| 215 | Phosphorylation | VRLGLQYSQGLVSGS HHHCCEECCCCCCCC | 12.57 | 28857561 | |
| 281 | Ubiquitination | HNAIKFLNKEITSVG HHHHHHHCHHHHCCC | 42.94 | 21890473 | |
| 282 (in isoform 1) | Ubiquitination | - | 53.28 | 21890473 | |
| 282 | Ubiquitination | NAIKFLNKEITSVGS HHHHHHCHHHHCCCC | 53.28 | 21890473 | |
| 285 | Phosphorylation | KFLNKEITSVGSSKR HHHCHHHHCCCCCHH | 20.60 | 29514088 | |
| 286 | Phosphorylation | FLNKEITSVGSSKRE HHCHHHHCCCCCHHH | 30.09 | 29514088 | |
| 289 | Phosphorylation | KEITSVGSSKREEEA HHHHCCCCCHHHHHH | 30.45 | 29514088 | |
| 290 | Phosphorylation | EITSVGSSKREEEAK HHHCCCCCHHHHHHH | 29.78 | 29514088 | |
| 291 | 2-Hydroxyisobutyrylation | ITSVGSSKREEEAKS HHCCCCCHHHHHHHH | 66.58 | - | |
| 291 | Ubiquitination | ITSVGSSKREEEAKS HHCCCCCHHHHHHHH | 66.58 | - | |
| 297 | Ubiquitination | SKREEEAKSELRAAI CHHHHHHHHHHHHHH | 47.98 | - | |
| 302 (in isoform 2) | Ubiquitination | - | 22.76 | 21890473 | |
| 303 (in isoform 2) | Ubiquitination | - | 9.59 | 21890473 | |
| 328 | Phosphorylation | RFAYQKISNGDVILV HHHHHHCCCCCEEEE | 41.62 | 21712546 | |
| 339 | Phosphorylation | VILVYGCSSLVSRIL EEEEECCHHHHHHHH | 23.50 | 27251275 | |
| 340 | Phosphorylation | ILVYGCSSLVSRILQ EEEECCHHHHHHHHH | 36.55 | 21712546 | |
| 360 (in isoform 2) | Phosphorylation | - | 3.47 | 27251275 | |
| 374 | Methylation | LEGRHTLRSLVHAGV CCCHHHHHHHHHCCC | 29.15 | - | |
| 384 | Phosphorylation | VHAGVPASYLLIPAA HHCCCCHHHHHHCHH | 15.39 | 22817900 | |
| 385 | Phosphorylation | HAGVPASYLLIPAAS HCCCCHHHHHHCHHH | 13.97 | 22817900 | |
| 399 | Phosphorylation | SYVLPEVSKVLLGAH HHHCHHHHHHHHHHH | 18.51 | 22817900 | |
| 442 | Ubiquitination | LVCCETYKFCERVQT EEECCHHHHHHHHCC | 51.46 | - | |
| 466 (in isoform 1) | Ubiquitination | - | 50.94 | 21890473 | |
| 466 | Acetylation | DPDDLQCKRGEHVAL CHHHCCCCCCCCEEE | 50.94 | 24846367 | |
| 466 | Ubiquitination | DPDDLQCKRGEHVAL CHHHCCCCCCCCEEE | 50.94 | 2190698 | |
| 486 (in isoform 2) | Ubiquitination | - | 31.86 | - | |
| 487 (in isoform 2) | Ubiquitination | - | 3.68 | 21890473 | |
| 489 | Phosphorylation | LRLLNLVYDVTPPEL HHHHHHHCCCCCHHH | 14.09 | 22210691 | |
| 492 | Phosphorylation | LNLVYDVTPPELVDL HHHHCCCCCHHHHHH | 30.17 | 22210691 | |
| 510 | Phosphorylation | ELGMIPCSSVPVVLR CCCCEECCCCCEEEE | 29.08 | 22210691 | |
| 511 | Phosphorylation | LGMIPCSSVPVVLRV CCCEECCCCCEEEEE | 36.84 | 22210691 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EI2BD_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EI2BD_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EI2BD_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| EI2BE_HUMAN | EIF2B5 | physical | 10858531 | |
| EI2BE_HUMAN | EIF2B5 | physical | 22939629 | |
| EI2BG_HUMAN | EIF2B3 | physical | 22939629 | |
| EI2BB_HUMAN | EIF2B2 | physical | 25416956 | |
| EI2BA_HUMAN | EIF2B1 | physical | 26344197 | |
| IF2A_HUMAN | EIF2S1 | physical | 26344197 | |
| ZN622_HUMAN | ZNF622 | physical | 26344197 | |
| EI2BA_HUMAN | EIF2B1 | physical | 27173435 | |
| EI2BB_HUMAN | EIF2B2 | physical | 27173435 | |
| MCU_HUMAN | MCU | physical | 27173435 | |
| BZW2_HUMAN | BZW2 | physical | 27173435 | |
| EI2BE_HUMAN | EIF2B5 | physical | 27173435 | |
| GDIR1_HUMAN | ARHGDIA | physical | 27173435 | |
| EI2BG_HUMAN | EIF2B3 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 603896 | Leukodystrophy with vanishing white matter (VWM) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-86 AND SER-399, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130 AND THR-137, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-137, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-86, AND MASSSPECTROMETRY. | |